| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
notch receptor 3 | 0.435 | 0.808 | 0.41 |
|
group | 0.500 | strong | 0.933 | 15 | 3 | 2000 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily M member 8 | 0.553 | 0.808 | 4.6E-29 |
|
group | 0.500 | None | 0.917 | 12 | 4 | 2011 | 2019 | ||||||||
|
PR/SET domain 16 | 0.522 | 0.808 | 1.00 |
|
group | 0.480 | None | 0.909 | 11 | 4 | 2011 | 2020 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
group | 0.480 | None | 1.000 | 11 | 1 | 2011 | 2018 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
group | 0.420 | None | 0.667 | 3 | 0 | 2006 | 2014 | ||||||||
|
succinyl-CoA:glutarate-CoA transferase | 0.686 | 0.385 | 2.8E-09 |
|
group | 0.410 | None | 0.750 | 4 | 3 | 2013 | 2016 | ||||||||
|
four and a half LIM domains 5 | 0.530 | 0.769 | 4.8E-10 |
|
group | 0.410 | None | 0.750 | 4 | 4 | 2013 | 2016 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
group | 0.400 | None | 0.980 | 199 | 0 | 2003 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
group | 0.400 | None | 0.958 | 24 | 1 | 2003 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.938 | 16 | 3 | 2004 | 2017 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
group | 0.400 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
group | 0.340 | None | 0.600 | 5 | 1 | 1996 | 2010 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit theta | 0.722 | 0.500 | 4.3E-03 |
|
group | 0.330 | limited | 1.000 | 4 | 1 | 2008 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
group | 0.210 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
group | 0.200 | None | 0.969 | 32 | 6 | 1998 | 2019 | ||||||||
|
mitofusin 1 | 0.644 | 0.577 | 2.5E-10 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
proline rich transmembrane protein 2 | 0.448 | 0.808 | 0.58 |
|
group | 0.180 | None | 0.875 | 8 | 0 | 2000 | 2019 | ||||||||
|
myocyte enhancer factor 2D | 0.608 | 0.500 | 1.00 |
|
group | 0.130 | None | 0.714 | 7 | 7 | 2012 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
group | 0.130 | None | 0.333 | 3 | 1 | 2006 | 2013 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.120 | None | 1.000 | 3 | 2 | 2009 | 2015 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.120 | None | 1.000 | 2 | 0 | 2005 | 2013 | |||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.120 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
solute carrier family 1 member 3 | 0.573 | 0.577 | 0.99 |
|
group | 0.120 | None | 1.000 | 2 | 0 | 2009 | 2017 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
group | 0.120 | None | 1.000 | 2 | 1 | 2013 | 2016 | ||||||||
|
OPA1 mitochondrial dynamin like GTPase | 0.510 | 0.846 | 0.99 |
|
group | 0.120 | None | 1.000 | 2 | 0 | 2017 | 2017 |